When was Bioenterprise founded?

Bioenterprise was founded in 2003.

Where is Bioenterprise's headquarters located?

Bioenterprise's headquarters is located in Guelph (Canada).

How big is Bioenterprise's investment team?

Bioenterprise has a team of 31, including 9 partners.

How many companies has Bioenterprise invested in?

Bioenterprise has invested in 65 companies, including Vive & Sollum Technologies.

Which companies has Bioenterprise invested in lately?

Farm Health Guardian & Harvest Genomics are the latest investments by Bioenterprise.

How many exits has Bioenterprise been involved in?

Bioenterprise's portfolio has seen 2 acquisitions.

Bioenterprise - 2026 Investor Profile, Portfolio, Team & Investment Trends

1. Vive

Precision chemistry for crop protection, increasing grower ROI, efficiency, and sustainability. They develop products and technologies to help growers achieve better results with less impact. Their Allosperse® Delivery Technology enables targeted solutions, improving crop quality and yields. They offer a range of products including fungicides, insecticides, miticides, and nematicides, suitable for diverse crops. They focus on innovative solutions for sustainable agriculture. They are committed to developing cutting-edge products that create real results for growers.

Key facts about Vive

Founded Year: 2006
Location: Mississauga (Canada)
Stage: Series C
Total Funding till date: $72.1M
Employee Count: 49 as on May 27, 2025
Investors: MaRS Discovery District, Export Development Canada and 21 Others
Latest Funding Round: Series C, Oct 2025, $*****
Highlight: Editors' Pick

2. Sollum Technologies

Dynamic LED lighting solutions for greenhouses, optimizing plant growth and productivity. They offer a comprehensive dynamic lighting technology, including smart fixtures, a cloud platform, and support. Their solution recreates natural sunlight, delivering ideal light recipes for various crops, regardless of location. This leads to increased productivity, better taste, and longer shelf life. They provide flexible LED fixtures, AI-powered by their cloud platform, supported by agronomists and technical specialists. They focus on innovation and pragmatic solutions to balance costs, crop growth, product quality, and sustainability. They offer smart support, including planning, installation, training, and monitoring. They are a cleantech company, offering energy-efficient solutions. They are a B2B company, offering a SaaS platform.

Key facts about Sollum Technologies

Founded Year: 2015
Location: Montreal (Canada)
Stage: Series B
Total Funding till date: $42M
Employee Count: 50 as on Aug 31, 2026
Investors: National Bank of Canada, Real Ventures and 12 Others
Latest Funding Round: Series B, Jan 16, 2023, $*****
Highlight: Editors' Pick

3. Terramera

Developer of biological crop protection formulations and soil intelligence technologies. They offer solutions for biological actives, delivery technologies, and stability enhancers. The company provides soil measurement and analysis, using sensing, signal processing, machine learning, and computational chemistry. The company focuses on sustainable agriculture practices.

Key facts about Terramera

Founded Year: 2010
Location: Vancouver (Canada)
Stage: Series C
Total Funding till date: $64.9M
Employee Count: 23 as on Aug 31, 2026
Investors: Western Technology Investment, Northview LifeSciences and 22 Others
Latest Funding Round: Series C, Jan 12, 2023, $*****
Highlight: Editors' Pick

4. SomaDetect

AI-driven solution for measuring somatic cell count for early detection of mastitis. The system reads the distinct patterns of light from a laser signal traveling through a sample. The captured information is sent to an online server and analyzed to generate reports for farmers. The reports are sent to farmers through email or cell phones.

Key facts about SomaDetect

Founded Year: 2016
Location: Tillsonburg (Canada)
Stage: Series A
Total Funding till date: $8.25M
Employee Count: 12 as on Aug 31, 2026
Investors: iGan Partners, Cavallo Ventures and 15 Others
Latest Funding Round: Series A, Mar 02, 2021, $*****
Highlight: Editors' Pick

5. Neurodyn

Neurodyn focuses on developing bio-actives for neuroprotection and the early treatment of neurological diseases (Parkinson’s, Alzheimer’s, ALS and chronic nerve pain). Neurodyn preferentially isolates BioActive compounds within historically-proven natural treatments, creates new chemical entities where appropriate, validates those drug candidates and sells those assets for early returns. Its drug pipeline includes Memogain, a pro-drug of the plant-derived drug galantamine for the treatment of Alzheimer’s dementia (AD); ND1208, saponin-based bio-active for protection of early-stage Parkinson’s disease; ND602 (biologic progranulin) for the treatment of Parkinson’s disease; NQ1123 for neuropathic pain relief.

Key facts about Neurodyn

Founded Year: 2006
Location: Charlottetown (Canada)
Stage: Series A
Total Funding till date: $13.7M
Investors: Mertz Holdings, Prince Edward Island and 4 Others
Latest Funding Round: Series A, Oct 09, 2019, $*****
Highlight: Editors' Pick

View the full list of portfolio companies

Bioenterprise has invested in 65 companies over the last 10 years, with an average of 2 new investments annually in the last 10 years. Its most recent first time investment was in Farm Health Guardian and most recent follow-on round was in Korechi Innovations.

Here are Bioenterprise's Year-on-Year Investment Trends:

Year	No. of Investments
Year	1^st Round	Follow-on	Total
2026 (YTD)	0	0	0
2025	0	0	0
2024	0	0	0
2023	0	0	0
2022	4	1	5
2021	4	0	4
2020	0	0	0
2019	1	0	1
2018	2	0	2
2017	3	0	3

View all investments by Bioenterprise

Bioenterprise has made 14 investments in Seed stage with an average round size of $30K, 6 investments in Grant (prize money) stage with an average round size of $30K, 3 investments in Unattributed stage with an average round size of $30K and 1 investment in Series A stage with an average round size of $30K.

Here are Bioenterprise's investments by stage:

Stage of entry	No. of Investments
Seed	14
Grant (prize money)	6
Unattributed	3
Series A	1

Note: We have considered here, only first round of investments

View all investments by Bioenterprise

Bioenterprise has a diverse portfolio, with companies operating in the Food and Agriculture Tech, Food and Agriculture, High Tech, Enterprise Applications and Sustainability Tech. Notably, it has invested in 31 Enterprise (B2B) companies, 31 Tech companies, 13 Tech hardware companies and at least 12 companies focusing on Software.

Here are Bioenterprise's investments by sector:

Sector	No. of Investments
Food and Agriculture Tech	10
Food and Agriculture	5
High Tech	5
Enterprise Applications	4
Sustainability Tech	4
Others	18

Note: We have considered here, only first round of investments

View all investments by Bioenterprise

Bioenterprise has made most investments in Canada (23), followed by United Kingdom where it has made 1 investment.

Here are Bioenterprise's investments by geography:

Country	No. of Investments
Canada	23
United Kingdom	1

Note: We have considered here, only first round of investments

View all investments by Bioenterprise

Bioenterprise has not made any investment in 2026 so far.

Here are the most recent investments by Bioenterprise:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
Apr 05, 2022	Farm Health Guardian	Canada	Grant (prize money)	5485	-
Apr 05, 2022	Harvest Genomics	Canada	Grant (prize money)	1273	-
Apr 05, 2022	Grain Discovery	Canada	Grant (prize money)	7437	-
Apr 05, 2022	Korechi Innovations	Canada	Grant (prize money)	4622	-
Apr 05, 2022	AUG Signals	Canada	Grant (prize money)	3699	-

See more recent investments made by Bioenterprise

2 companies from Bioenterprise's portfolio have been acquired. The most recent acquisition was Grain Discovery in Jul 2025 by DTN for $*****.

Here are Bioenterprise's portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Grain Discovery	Jul 23, 2025	Apr 05, 2022	Grant (prize money)	1512
Mustard Products & Technologies	Jul 05, 2017	-	-	4827

View all acquired companies in Bioenterprise's portfolio

Bioenterprise has a team of 31 members including 9 Partners located in Canada and United States. Bioenterprise's team sits on the board of 2 companies.

Here is a list of top team members in Bioenterprise:

Name	Designation	Location	Board Memberships	Contact Details
Dave Smardon	Partner	Ottawa	-	1 Email
Richard Cloutier	Partner	Ottawa	INNO-3B and AecopaQ	1 Email, 2 Phone numbers
Italo Cerra	Partner	Canada	-	1 Email
Lorelei Graham	Partner	Canada	-	-
Joanne Fedeyko	Partner	San Francisco	-	1 Email
James Meddings	Partner	Ottawa	-	-
Carla Berquo	Partner	Canada	-	1 Email
Paul Richards	Partner	Canada	-	-
Michael McGee	Partner	Calgary	-	1 Email
Scott Ross	Partner	Ottawa	-	1 Email

View team details of Bioenterprise

Over the past 10 years, 31 investors have co-invested in Bioenterprise's portfolio companies. This includes funds and angels.

Invested before Bioenterprise: ontariocapitalgrowth.ca, Sustainable Chemistry Alliance and 7 others have invested in rounds before Bioenterprise. There is 1 company where ontariocapitalgrowth.ca has invested before Bioenterprise and 1 company where Sustainable Chemistry Alliance has invested before Bioenterprise.
Top Co-investors of Bioenterprise: 4 investors entered a company along with Bioenterprise. These include investors like Greenspring Bioinnovation Hub (4 companies).
Invested after Bioenterprise: A total of 18 investors have invested in Bioenterprise's portfolio after their investments. Top Investors include Cibus Fund (1 company) and BDC (1 company).